Format

Send to

Choose Destination
N Engl J Med. 2011 Jul 14;365(2):97-9. doi: 10.1056/NEJMp1106783. Epub 2011 Jun 15.

The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

Author information

1
Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
PMID:
21675880
DOI:
10.1056/NEJMp1106783
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center